PHARMACOTHERAPEUTIC STATURE OF DOXAZOSIN AND ITS ROLE IN CORONARY RISK REDUCTION

被引：24

作者：

TAYLOR, SH ^{[1
]}

机构：

[1] UNIV LEEDS,GEN INFIRM,DEPT MED CARDIOL,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND

来源：

AMERICAN HEART JOURNAL | 1988年 / 116卷 / 06期

关键词：

D O I：

10.1016/0002-8703(88)90223-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1735 / 1747

页数：13

共 24 条

[1] THE ALPHA-1-ADRENOCEPTOR ANTAGONIST PROFILE OF DOXAZOSIN - PRECLINICAL PHARMACOLOGY [J].

ALABASTER, VA ;

DAVEY, MJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S9-S17

[2]

BAILEY RR, 1985, NEW ZEAL MED J, V98, P248

[3] PHARMACOKINETICS AND EFFECT ON BLOOD-PRESSURE OF DOXAZOSIN IN NORMAL SUBJECTS AND PATIENTS WITH RENAL-FAILURE [J].

CARLSON, RV ;

BAILEY, RR ;

BEGG, EJ ;

COWLISHAW, MG ;

SHARMAN, JR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (05) :561-566

[4]

CHICHESTER CO, 1987, J CARDIOVASC PHARM, V10, pS21

[5] CLINICAL-PHARMACOLOGY OF DOXAZOSIN IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].

CUBEDDU, LX ;

FUENMAYOR, N ;

CAPLAN, N ;

FERRY, D .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) :439-449

[6] CLINICAL PHARMACOLOGICAL STUDIES WITH DOXAZOSIN [J].

ELLIOTT, HL ;

MEREDITH, PA ;

VINCENT, J ;

REID, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S27-S31

[7] PHARMACOKINETIC OVERVIEW OF DOXAZOSIN [J].

ELLIOTT, HL ;

MEREDITH, PA ;

REID, JL .

AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (14) :G78-G81

[8] A LONG-TERM DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].

FRICK, MH ;

HALTTUNEN, P ;

HIMANEN, P ;

HUTTUNEN, M ;

PORSTI, P ;

PITKAJARVI, T ;

POYHONEN, L ;

PYYKONEN, ML ;

REINIKAINEN, P ;

SALMELA, P ;

SARASTE, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S55-S62

[9] HEPATIC VASCULAR BED [J].

GREENWAY, CV ;

STARK, RD .

PHYSIOLOGICAL REVIEWS, 1971, 51 (01) :23-+

[10]

JANSEN H, UNPUB J CARDIOVASC P

← 1 2 3 →